Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer—Spanish Lung Cancer Group Expert Consensus Statement

IF 3.6 Q2 ONCOLOGY

JTO Clinical and Research Reports Pub Date : 2026-06-01 Epub Date: 2026-04-09 DOI:10.1016/j.jtocrr.2026.101001

Aylen Vanessa Ospina-Serrano MD, MSc, PhD , Constanza Maximiano-Alonso MD, PhD , Pau Guillén-Sentís MD , Beatriz Losada MD , Patricia Cruz-Castellanos MD , Rafael López-Castro MD , Begoña Campos-Balea MD , Eider Azkona-Uribelarrea MD, PhD , Ana Cardeña MD , Augusto Valdivia MD , Alejandro Olivares-Hernández MD , Ana Blasco-Cordellat MD , María Sereno-Moyano MD, PhD , Delfina Peralta-Tanco MD , Manuel Dómine MD, PhD , Raquel Romão MD , Silvia Muñoz-Borrajo MD , Manuel Garcia-Espantaleon MD , Augusto Pereira-Sánchez MD , Esaú Fernández-Pascual MD , Mariano Provencio-Pulla MD, PhD

{"title":"Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer—Spanish Lung Cancer Group Expert Consensus Statement","authors":"Aylen Vanessa Ospina-Serrano MD, MSc, PhD , Constanza Maximiano-Alonso MD, PhD , Pau Guillén-Sentís MD , Beatriz Losada MD , Patricia Cruz-Castellanos MD , Rafael López-Castro MD , Begoña Campos-Balea MD , Eider Azkona-Uribelarrea MD, PhD , Ana Cardeña MD , Augusto Valdivia MD , Alejandro Olivares-Hernández MD , Ana Blasco-Cordellat MD , María Sereno-Moyano MD, PhD , Delfina Peralta-Tanco MD , Manuel Dómine MD, PhD , Raquel Romão MD , Silvia Muñoz-Borrajo MD , Manuel Garcia-Espantaleon MD , Augusto Pereira-Sánchez MD , Esaú Fernández-Pascual MD , Mariano Provencio-Pulla MD, PhD","doi":"10.1016/j.jtocrr.2026.101001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Sexual dysfunction (SD) is a common adverse effect of oncologic treatment; however, sexual health assessment is not routinely included in the follow-up of persons with lung cancer (LC).</div></div><div><h3>Methods</h3><div>The Spanish Lung Cancer Group conducted a formal consensus process to develop recommendations for a multidisciplinary approach to SD in persons with LC. Mixed methods combining a modified Delphi technique and a nominal group process were used to guide the discussions on the selected topics.</div></div><div><h3>Results</h3><div>The consensus process was conducted between May and October 2024. A panel of 28 Spanish experts—including medical oncologists, gynecologists, urologists, family physicians, sexologists, psychologists, one psychiatrist, and one oncology nurse—was convened to address the multidimensional aspects of sexuality. A 33-item questionnaire was developed for the voting process, which comprised two rounds followed by a final nominal group meeting. The threshold for agreement among experts was set at 85%. In cases in which scientific evidence was limited or controversial, recommendations were based on expert clinical experience. The primary topics addressed included patient education on SD, screening and follow-up strategies, the composition and role of the multidisciplinary team, referral criteria among team members, and both nonpharmacologic and pharmacologic management of SD.</div></div><div><h3>Conclusions</h3><div>This document presents the suggestions developed through expert panel discussions and summarizes the available scientific evidence supporting them. Given the absence of specific guidelines addressing sexual health assessment through oncologic follow-up of people with LC, this consensus may help improve clinical care and quality of life for this population in real-world practice.</div></div>","PeriodicalId":17675,"journal":{"name":"JTO Clinical and Research Reports","volume":"7 6","pages":"Article 101001"},"PeriodicalIF":3.6000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTO Clinical and Research Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666364326000524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Sexual dysfunction (SD) is a common adverse effect of oncologic treatment; however, sexual health assessment is not routinely included in the follow-up of persons with lung cancer (LC).

Methods

The Spanish Lung Cancer Group conducted a formal consensus process to develop recommendations for a multidisciplinary approach to SD in persons with LC. Mixed methods combining a modified Delphi technique and a nominal group process were used to guide the discussions on the selected topics.

Results

The consensus process was conducted between May and October 2024. A panel of 28 Spanish experts—including medical oncologists, gynecologists, urologists, family physicians, sexologists, psychologists, one psychiatrist, and one oncology nurse—was convened to address the multidimensional aspects of sexuality. A 33-item questionnaire was developed for the voting process, which comprised two rounds followed by a final nominal group meeting. The threshold for agreement among experts was set at 85%. In cases in which scientific evidence was limited or controversial, recommendations were based on expert clinical experience. The primary topics addressed included patient education on SD, screening and follow-up strategies, the composition and role of the multidisciplinary team, referral criteria among team members, and both nonpharmacologic and pharmacologic management of SD.

Conclusions

This document presents the suggestions developed through expert panel discussions and summarizes the available scientific evidence supporting them. Given the absence of specific guidelines addressing sexual health assessment through oncologic follow-up of people with LC, this consensus may help improve clinical care and quality of life for this population in real-world practice.

查看原文本刊更多论文

肺癌患者性功能障碍的多学科方法-西班牙肺癌组专家共识声明

背景：性功能障碍（SD）是肿瘤治疗中常见的不良反应；然而，性健康评估并未常规纳入肺癌患者的随访（LC）。方法：西班牙肺癌研究小组进行了正式的共识过程，以制定多学科方法治疗肺癌患者SD的建议。结合改进的德尔菲技术和名义小组过程的混合方法被用来指导对选定主题的讨论。结果共识过程于2024年5月至10月进行。一个由28名西班牙专家组成的小组——包括医学肿瘤学家、妇科医生、泌尿科医生、家庭医生、性学家、心理学家、一名精神病学家和一名肿瘤学护士——被召集起来讨论性的多维方面。为投票过程编制了一份有33个项目的调查表，投票过程包括两轮，然后是最后一次名义上的小组会议。专家之间达成一致的门槛设定为85%。在科学证据有限或有争议的情况下，建议以专家临床经验为基础。主要讨论的主题包括对SD的患者教育、筛查和随访策略、多学科团队的组成和作用、团队成员之间的转诊标准以及SD的非药物和药物管理。本文件介绍了通过专家小组讨论提出的建议，并总结了支持这些建议的现有科学证据。鉴于缺乏通过肿瘤随访对LC患者进行性健康评估的具体指南，这一共识可能有助于改善现实世界中这一人群的临床护理和生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊